Description
| Product Name | CAT.No | Size |
| FACTOR II ASSAY KIT | COAG129A | 5 x 1ml; 1 x 60ml |
| FACTOR IX ASSAY KIT | COAG127A | 5 x 1ml; 1 x 60ml |
| FACTOR V ASSAY KIT | COAG128A | 5 x 1ml; 1 x 60ml |
| FACTOR VII ASSAY KIT | COAG124A | 5 x 1ml; 1 x 60ml |
| FACTOR VIII ASSAY KIT | COAG122A | 5 x 1ml; 1 x 60ml |
| FACTOR X ASSAY KIT | COAG123A | 5 x 1ml; 1 x 60ml |
| FACTOR XI ASSAY KIT | COAG133A | 5 x 1ml; 1 x 60ml |
| FACTOR XII ASSAY KIT | COAG126A | 5 x 1ml; 1 x 60ml |
Product Description
The Biorex Diagnostics Factor Deficient Substrate Plasma Assays are specialised in vitro diagnostic tools designed for the quantitative determination of individual coagulation factors in patients with suspected congenital or acquired clotting abnormalities. These assays support comprehensive evaluation of haemostasis and provide critical data to aid in diagnosing blood coagulation disorders, guiding therapeutic decision-making, and monitoring patient response to treatment. Their precise analytical performance makes them suitable for routine testing within clinical laboratories and hospital-based coagulation services.
Developed to deliver sensitivity, specificity, and reproducibility, the assays enable accurate measurement of specific factor activity across a range of common and rare deficiencies. The versatile design accommodates testing for several key coagulation factors – including II, V, VII, VIII, IX, X, XI, XII, and XIII – ensuring broad diagnostic coverage and compatibility with diverse patient presentations. Manufactured under stringent quality controls, the Biorex Factor Deficient Substrate Plasma Assays provide consistent results that enhance diagnostic confidence and support optimal patient care within the field of haemostasis.
Key Features
- Quantitative determination of individual coagulation factors
- Sensitive and specific detection of congenital and acquired deficiencies
- Broad applicability across factors II, V, VII, VIII, IX, X, XI, XII, XIII
- Supports clinical decision-making in bleeding disorder evaluation
- Reliable and reproducible performance under rigorous quality standards
Benefits
The Biorex Factor Assays enable accurate and clinically meaningful assessment of coagulation factor activity, assisting healthcare professionals in diagnosing factor deficiencies, monitoring therapeutic interventions, and personalising management strategies for patients with bleeding or clotting disorders. Their quantitative and versatile design facilitates effective haemostasis evaluation and contributes to improved clinical outcomes in both routine and specialised coagulation investigations.
Contact Us for more information.